Username Password
S&P 500: 1,340.35 Change: -0.84%
2dimes
P&P Score: 21.28 | Points: 0.00 | Accuracy: 20.00 | Average Pick Score: -5.67   Annual Return: N/A  
Open
 
Closed
 
All
 
Commentary
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $52.47
Points: +120.67
Created: 08/12/2008
Recent negative price gap due to possible side effects of Multiple Sclerosis Drug Tysabri will be resolved near term allowing price Target of 75 near term and 95 in 1st quarter 2009

Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.

register
Sponsored Links